Last-Resort access: Lab-Grown vessel offered to patients with no other options
Disease control
TEMPORARILY_NOT_AVAILABLE
This program provides individual patient access to an acellular tissue engineered vessel (ATEV) for people with vascular disease or end-stage renal disease on dialysis who have no other treatment options and cannot join a clinical study. The ATEV is a lab-made blood vessel design…
Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated May 17, 2026 08:54 UTC